Ironwood Pharmaceuticals IRWD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $106.51M+123% | $47.71M-60.9% | $122.06M+43.2% | $85.24M+107% | $41.14M-54.6% | ||
| $21.94M+0.4% | $21.86M-2.7% | $22.47M-3.9% | $23.37M-14.8% | $27.43M+8.0% | ||
| $12.03M-37.6% | $19.29M-11.9% | $21.91M+30.4% | $16.8M-30.8% | $24.26M-27.8% | ||
| $33.93M-17.0% | $40.9M-12.2% | $46.58M+16.7% | $39.92M-43.2% | $70.25M+19.0% | ||
| $72.57M+966% | $6.81M-91.0% | $75.48M+66.6% | $45.32M+256% | -$29.11M-192% | ||
| 68.1%+53.9pp | 14.3%-47.6pp | 61.8%+8.7pp | 53.2%+124pp | -70.7%-106pp | ||
| $9.14M+15.9% | $7.89M-6.5% | $8.43M+0.9% | $8.36M+3.5% | $8.07M-9.5% | ||
| -$7.4M-16.6% | -$6.35M+14.9% | -$7.46M+0.5% | -$7.5M-4.7% | -$7.16M+4.4% | ||
| $65.17M+14,224% | $455K-99.3% | $68.02M+79.8% | $37.82M+204% | -$36.27M-251% | ||
| $24.4M+793% | $2.73M-90.2% | $27.94M+96.4% | $14.22M+1,177% | $1.11M-94.9% | ||
| $40.77M+1,891% | -$2.28M-106% | $40.08M+69.8% | $23.6M+163% | -$37.39M-1,757% | ||
| 38.3%+43.1pp | -4.8%-37.6pp | 32.8%+5.2pp | 27.7%+119pp | -90.9%-93.4pp | ||
| $0.24+2,500% | -$0.01-104% | $0.23+64.3% | $0.14+161% | -$0.23-2,400% | ||
| $73.02M+905% | $7.27M-90.4% | $75.96M+65.9% | $45.79M+260% | -$28.63M-190% | ||
| 68.6%+53.3pp | 15.2%-47.0pp | 62.2%+8.5pp | 53.7%+123pp | -69.6%-105pp | ||
| $72.57M+966% | $6.81M-91.0% | $75.48M+66.6% | $45.32M+256% | -$29.11M-192% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
